Catalyst Wire Dossier Catalyst Wire Dossier

Clobetasone butyrate 0.05% cream

clobetasone butyrate · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clobetasone butyrate 0.05% cream, covering 2017-11-28 to 2017-11-28. Get the full timeline:

Most recent: Clinical Trial Update: Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety [Phase 3]

See pricing